Distinct responses of mouse hepatic CYP enzymes to corn oil and peroxisome proliferators

Biochemical Pharmacology

Volumn 51, Issue 9, 1996, Pages 1137-1143

  Kojo, Anneli ^a   Pellinen, Pertti ^a   Juvonen, Risto ^a   Raunio, Hannu ^b   Pelkonen, Olavi ^b   Pasanen, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

clofibrate; corn oil; coumarin 7 hydroxylase; gemfibrozil; liver; mouse

Indexed keywords

CLOFIBRATE; CORN OIL; COUMARIN 7 HYDROXYLASE; CYTOCHROME P450 ISOENZYME; ETHOXYRESORUFIN DEETHYLASE; GEMFIBROZIL; LIVER ENZYME; MESSENGER RNA; PEROXISOME PROLIFERATOR; SOLVENT; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

EID: 0029970521     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00027-5     Document Type: Article

References (44)

1. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K and Nebert DW, The P450 super-family: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12: 1-51, 1993.
2. Negishi M, Lindberg R, Burkhart B, Ichikawa T, Honkakoski P and Lang M, Mouse steroid 15α-hydroxylase gene family: identification of Type II P-45015α as coumarin 7-hydroxylase. Biochemistry 28: 4169-4172, 1989.
3. Squires EJ and Negishi M, Reciprocal regulation of sex-dependent expression of testosterone 15α-hydroxylase (P-45015α) in liver and kidney of male mice by androgen. Evidence for a single gene. J Biol Chem 263: 4166-4171, 1988.
4. Yamano S, Tatsuno J and Gonzalez FJ, The CYP2A3 gene product catalyses coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29: 1322-1329, 1990.
5. 7α cDNA and regulation by sex and dexamethasone in mouse liver. In: Drug Metabolizing Enzymes: Genetics, Regulation and Toxicology. Proceedings of the VIIIth Jutland Symposium on Microsomes and Drug Oxidations, Stockholm, Sweden (Eds. Ingelman-Sundberg M, Gustafsson J-Å and Orrenius S), p. 135, 1990.
6. Wood AW and Conney AH, Genetic variation in coumarin hydroxylase activity in the mouse (Mus musculus). Science 185: 612-613, 1974.
7. Juvonen RO, Kaipainen PK and Lang MA, Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice. Eur J Biochem 152: 3-8, 1985.
8. Kojo A, Heiskanen R, Rytkönen A-L, Honkakoski P, Juvonen R and Lang M, Inducibility of P450Coh by pyrazole and its derivatives. Biochem Pharmacol 42: 1751-1759, 1991.
9. Pellinen P, Stenbäck F, Rautio A, Pelkonen O, Lang M and Pasanen M, Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases. Naunyn-Schmiedeberg's Arch Pharmacol 348: 435-443, 1993.
10. Mäenpää J, Sigusch H, Raunio H, Syngelmä T, Vuorela P, Vuorela H and Pelkonen O, Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem Pharmacol 45: 1035-1042, 1993.
11. Kojo A, Honkakoski P, Järvinen P, Pelkonen O and Lang M, Preferential inhibition of mouse hepatic coumarin 7-hydroxylase by inhibitors of steroid metabolizing monooxygenases. Pharmacol Toxicol 65: 104-109, 1989.
12. Bentley P, Calder I, Elcombe C, Grasso P, Stringer D and Wiegand H-J, Hepatic peroxisome proliferation in rodents and its significance for humans. Fd Chem Toxicol 31: 857-907, 1993.
13. Gibson GG, Peroxisome proliferators: paradigms and prospects. Toxicol Letters 68: 193-201, 1993.
14. tu) from mouse liver tumors. Biochim Biophys Acta 1038: 130-135, 1990.
15. Lang MA and Nebert DW, Structural gene products of the Ah locus. Evidence for many unique P-450-mediated monooxygenase activities reconstituted from 3-methylcholantrene-treated C57BL/6N mouse liver microsomes. J Biol Chem 256: 12058-12067, 1981.
16. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC, Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
17. Omura T and Sato R, The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem 239: 2379-2385, 1964.
18. Aitio A, A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 85: 488-491, 1978.
19. Juvonen RO, Shkumatov VM and Lang MA, Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice. Eur J Biochem 171: 205-211, 1988.
20. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T and Mayer RT, Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34: 3337-3345, 1985.
21. Honkakoski P and Lang MA, Mouse liver phenobarbital-inducible P450 system: purification, characterization, and differential inducibility of four cytochrome P450 isozymes from the D2 mouse. Arch Biochem Biophys 273: 42-57, 1989.
22. Strobel HW and Dignam JD, Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol 52: 89-96, 1978.
23. Waxman DJ, Ko D and Walsh C, Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J Biol Chem 258: 11937-11947, 1983.
24. Chomczynski P and Sacchi N, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
25. Chan YL, Cutell R, Noller HF and Wool IG, The nucleotide sequence of a rat 18S ribosomal ribonucleic acid gene and a proposal for the secundary structure of 18S ribosomal ribonucleic acid. J Biol Chem 259: 224-229, 1981.
26. Lang MA, Juvonen RO, Järvinen P, Honkakoski P and Raunio H, Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes. Arch Biochem Biophys 271: 139-148, 1989.
27. Raunio H, Kojo A, Juvonen R, Honkakoski P, Järvinen P, Lang MA, Vähäkangas K, Gelboin HV, Park S-S and Pelkonen O, Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis-[2-(3,5-dichloropyridyloxy)]-benzene, pyrazole, and phenobarbital. Biochem Pharmacol 37: 4141-4147, 1988.
28. Kocer Z, Raunio H, Pasanen M, Arvela P, Raiskila T, Honkakoski P, Lang MA, Negishi M and Pelkonen O, Comparison between cobalt and pyrazole in the increased expression of coumarin 7-hydroxylase in mouse liver. Biochem Pharmacol 41: 462-465, 1991.
29. Pellinen P, Stenbäck F, Raunio H, Pelkonen O and Pasanen M, Modification of hepatic cytochrome P450 profile by cocaine-induced hepatotoxicity in DBA/2N mouse. Eur J Pharmacol 292: 57-65, 1994.
30. Milton MN, Elcombe CR and Gibson GG, On the mechanism of induction of microsomal cytochrome P450IV and peroxisome proliferation in rat liver by clofibrate. Biochem Pharmacol 40: 2727-2732, 1990.
31. Dreyer C, Keller H, Mahfoudi A, Laudet V, Krey G and Wahli W, Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol Cell 77: 67-76, 1993.
32. Salonpää P, Iscan M, Pasanen M, Arvela P, Pelkonen O and Raunio H, Cerium-induced strain-dependent increase in Cyp2a-4/5 (Cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice. Biochem Pharmacol 44: 1269-1274, 1992.
33. Wortelboer HM, de Kruif CA, van Iersel AAJ, Falke HE, Noordhoek J and Blaauboer BJ, Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. Biochem Pharmacol 42: 381-390, 1991.
34. Sharma R, Lake BG, Foster J and Gibson GG, Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship. Biochem Pharmacol 37: 1193-1201, 1988.
35. Yang CS and Yoo J-SH, Dietary effects on drug metabolism by the mixed-function oxidase system. Pharmacol Ther 38: 53-72, 1988.
36. Wade AE, White RA, Walton LC and Bellows JT, Dietary fat - a requirement for induction of mixed-function oxidase activities in starved-refed rats. Biochem Pharmacol 34: 3747-3754, 1985.
37. Kim HJ, Choi ES and Wade AE, Effect of dietary fat on the induction of hepatic microsomal cytochrome P450 isozymes by phenobarbital. Biochem Pharmacol 39: 1423-1430, 1990.
38. Yoo J-SH, Smith TJ, Ning SM, Lee M-J, Thomas PE and Yang CS, Modulation of the levels of cytochromes P450 in rat liver and lung by dietary lipid. Biochem Pharmacol 43: 2535-2542, 1992.
39. McDanell RE, Beales D, Henderson L and Sethi JK, Effect of dietary fat on the in vitro hepatotoxicity of paracetamol. Biochem Pharmacol 44: 1303-1306, 1992.
40. Honkakoski P, Auriola S and Lang MA, Distinct induction profiles of three phenobarbital-responsive mouse liver cytochrome P450 isozymes. Biochem Pharmacol 43: 2121-2128, 1992.
41. Sanchez RM, Alegret M, Adzet T, Merlos M and Laguna JC, Differential inhibition of long-chain acyl-CoA hydrolases by hypolipidemic drugs in vitro. Biochem Pharmacol 43: 639-644, 1992.
42. Camus A-M, Geneste O, Honkakoski P, Béréziat J-C, Henderson CJ, Wolf CR, Bartsch H and Lang MA, High variability of nitrosaminc metabolism among individuals: role of cytochromes P4502A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol Carcinogen 7: 268-275, 1993.
43. Pelkonen P, Honkakoski P, Geneste O, Bartsch H and Lang MA, Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes. Biochem Pharmacol 46: 1681-1687, 1993.
44. Raunio H, Syngelmä T, Pasanen M, Juvonen R, Honkakoski P, Kairaluoma MA, Sotaniemi E, Lang MA and Pelkonen O, Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem Pharmacol 37: 3889-3895, 1988.